Form 4: BioCardia CEO Peter Altman Acquires 1,000 Shares

BioCardia's President and CEO, Peter Altman, purchased 1,000 shares of common stock at a price of $2.06 per share on December 23, 2024.

Summary

• Peter Altman, the President and CEO of BioCardia, Inc., acquired 1,000 shares of the company's common stock on December 23, 2024.
• The shares were purchased at a price of $2.06 per share.
• Following this transaction, Mr. Altman directly owns 106,581 shares of BioCardia common stock.

Sentiment

Score: 6

Explanation: The document is neutral in sentiment. It reports a routine transaction by an executive. The purchase could be seen as a positive sign, but it's not a major event.

Positives

• The CEO's purchase of shares could be seen as a positive sign of confidence in the company's future.

Industry Context

This is a standard SEC Form 4 filing, which is common for corporate insiders when they trade their company's stock. It provides transparency into the trading activities of key personnel.

Comparison to Industry Standards

• SEC Form 4 filings are a standard practice for publicly traded companies in the United States.
• The transaction is typical for executives who are acquiring or disposing of company stock.
• The filing is consistent with regulatory requirements for insider trading transparency.

Stakeholder Impact

• The purchase may have a minor positive impact on shareholder sentiment.

Key Dates

Keywords

BioCardia, BCDA, insider trading, stock purchase, Peter Altman, executive, common stock